The EEE virus is spreading in the US
The mosquito strikes again

A mosquito-borne virus is making a comeback: Eastern equine encephalitis (EEE). While not actually new, cases are extremely rare. Nonetheless, there have been higher instances than usual in the U.S. this year. If a case is severe, it has the potential to be deadly, and there is no cure or prevention for the disease. Illnesses like EEE are only going to become more common as the climate continues to warm.
What is EEE?
EEE has been spreading across the northeastern U.S. The virus is spread through mosquitos but is rare and deadlier than the West Nile virus. "Approximately 30% of people who develop severe eastern equine encephalitis die, and many survivors have ongoing neurologic problems," said the Centers for Disease Control and Prevention. "Definitely, I'd say New England and the Gulf Coast are the two areas in the U.S. where it's mainly occurred in the past," David Hamer, a professor of global health and medicine at the Boston University School of Public Health, said to The Hill. "Massachusetts has had hundreds of cases over a 70-year period," Hamer added. "There may not be any for a couple years, and then there's another case or two, although we believe that it may be occurring a little more frequently."
The good news is that most people do not experience symptoms. "In 95% of cases, the infection has no symptoms at all, and the person is really quite well and doesn't know they have the virus," Ruanne Barnabas, the chief of the Division of Infectious Diseases at Massachusetts General Hospital, said to The Hill. However, the virus creates a bad situation for people who do experience symptoms. "In 5% of cases, people do have symptoms, including fever and chills. And then it can actually affect the central nervous system, and they can develop confusion, abnormal movements and encephalitis as well." In the worst cases, EEE can lead to death. The disease also has no vaccines or medicines to prevent or treat it. Instead, people should protect themselves from mosquito bites by using insect repellant and wearing long sleeves.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Will EEE get worse?
Along with people, the disease has also appeared in animals including horses, llamas and alpacas. Approximately 90% of horses infected with EEE have died. Dogs and cats are at much lower risk. The disease is not transmissible between animals and can only be passed through mosquitos in both humans and animals. It is also difficult to determine who is most at risk for severe EEE. "If you look at the cases, it seems to hit, you know, young teenagers, 30-year-olds, 40-year-olds — I mean healthy people that don't have clear risk factors. And so, I think everybody needs to be cautious," Hamer said.
The growing prevalence of mosquito-borne illnesses is largely due to climate change. Mosquitos thrive in warmer temperatures, and their range is rapidly expanding. Diseases like EEE are also appearing in regions where the diseases were not present before. "We've got milder winters, we've got warmer summers and we've got extremes in both precipitation and drought," Theodore G. Andreadis, a researcher who studied mosquito-borne diseases at the Connecticut Agricultural Experiment Station, said to Grist. "The impact that this has on mosquito populations is probably quite profound."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Javier Milei's memecoin scandal
Under The Radar Argentinian president is facing impeachment calls and fraud accusations
By Chas Newkey-Burden, The Week UK Published
-
Who is actually running DOGE?
TODAY'S BIG QUESTION The White House said in a court filing that Elon Musk isn't the official head of Donald Trump's Department of Government Efficiency task force, raising questions about just who is overseeing DOGE's federal blitzkrieg
By Rafi Schwartz, The Week US Published
-
How does the Kennedy Center work?
The Explainer The D.C. institution has become a cultural touchstone. Why did Trump take over?
By Joel Mathis, The Week US Published
-
Oysters could help combat antibiotic resistance
Under the radar The mollusk shows infection-fighting abilities
By Devika Rao, The Week US Published
-
How Trump's executive orders are threatening scientific research
In the spotlight Agencies are purging important health information
By Devika Rao, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Sperm cells can carry past trauma in their DNA
Under the radar Your parent's past may be affecting your future
By Devika Rao, The Week US Published
-
IVM is a better treatment than IVF for some women
The Explainer A less painful, less costly option for treating infertility emerges
By Theara Coleman, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
America is leaving WHO. What does that mean for public health?
Today's Big Question Trump orders the withdrawal
By Joel Mathis, The Week US Published